跳至主要内容
临床试验/NCT06589063
NCT06589063招募中不适用

Transcatheter Aortic Valve Replacement in Severe Low Flow, Low Gradient Aortic Stenosis: the Multicenter LOW-TAVR Registry

University of Salerno1 个研究点 分布在 1 个国家目标入组 1,500 人开始时间: 2024年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
1,500
试验地点
1
主要终点
Composite of all-cause death and hospitalization for worsening heart failure

研究概览

简要总结

LOW-TAVR is a real-world, retrospective and prospective, multicenter Italian registry aimed at evaluating the characteristics and clinical outcomes of patients with severe low flow, low gradient aortic stenosis undergoing transcatheter aortic valve replacement (TAVR) and, in particular:

  • risk factors
  • gender differences
  • comorbidities
  • pharmacological treatment
  • TAVR procedural characteristics
  • periprocedural and in-hospital complications
  • clinical outcome at 30-day, 1-year, 2-year and 5-year follow-up

详细描述

LOW-TAVR is a real-world, retrospective and prospective, multicenter Italian registry aimed at evaluating the characteristics and clinical outcomes of patients with severe low flow, low gradient aortic stenosis (LFLG-AS) undergoing transcatheter aortic valve replacement (TAVR).

The register aims to include at least 1,500 patients diagnosed with LFLG-AS undergoing TAVR at the participating centres.

The inclusion criteria are:

  • LFLG-AS diagnosis according to current European Society of Cardiology guidelines
  • Age 18 years or older
  • Written informed consent

The exclusion criteria are:

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • LFLG-AS diagnosis according to current European Society of Cardiology guidelines
  • Age 18 years or older
  • Written informed consent

排除标准

  • LFLG-AS pseudo-severe or non-confirmed severe aortic stenosis
  • LFLG-AS referred for medical treatment or undergoing surgery

结局指标

主要结局

Composite of all-cause death and hospitalization for worsening heart failure

时间窗: 1 year

Death due to cardiac or non-cardiac cause and new hospitalization for worsening heart failure

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Gennaro Galasso

Professor

University of Salerno

研究点 (1)

Loading locations...

相似试验